Propranolol for airway hemangiomas: Case report of novel treatment
Authors:
- 31 July 2009
- journal article
- case report
- Published by Wiley in The Laryngoscope
- Vol. 119 (10) , 2051-2054
Abstract
Infantile hemangiomas arising in the trachea are rare. These lesions pose a management dilemma as several treatment options can provide safe management. Propranolol, a nonselective beta‐blocker, has recently been introduced as a novel modality for the treatment of proliferating hemangiomas. This report illustrates the successful management of tracheal hemangiomas using oral propranolol in a young patient with otherwise treatment‐resistant airway lesions. Despite various endoscopic therapeutic attempts, the patient remained stridulous with airway disease that persisted into the involution phase of the average hemangioma cycle. Within 6 weeks of beginning oral propranolol (2 mg/kg/day), her airway compromise was eliminated and she had complete resolution of endoscopically visible disease. No side effects from propranolol occurred. We propose that oral propranolol should be considered for use in airway hemangiomas. Laryngoscope, 2009Keywords
This publication has 8 references indexed in Scilit:
- More on Propranolol for Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and TreatmentPediatrics, 2006
- Pharmacologic Treatment of Chronic Pediatric HypertensionPediatric Drugs, 2005
- Management of subglottic hemangiomaCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2004
- Traitement par vincristine des hémangiomes graves du nourrissonArchives de Pédiatrie, 2004
- The Nonsurgical Management of Vascular LesionsFacial Plastic Surgery Clinics of North America, 2001
- Pediatric Psychopharmacologic Uses of Propranolol: Review and Case IllustrationsJournal of Child and Adolescent Psychiatric Nursing, 1990